a double-blind, randomised, placebo-controlled, phase 3 trialThe Lancet
www.thelancet.com
... Florian Hiemeyer, MSc, Aruna Mehra, MD, Barrett H Childs, MD, Prof Yuankai Shi, MD, Prof Pier Luigi Zinzani, MD. The Lancet Oncology. Volume 22 Issue 5 Pages ...
Full Record | Library WebsiteMacEwan University
library.macewan.ca
Florian Hiemeyer · Pier Luigi Zinzani · Vita Beckert · Lidia Mongay Soler · Barrett H. Childs · Dirk Garmann. Hide. Hide. Source. CPT: Pharmacometrics & Systems ...
Model‐Based Benefit/Risk Analysis for the Copanlisib ...Wiley
ascpt.onlinelibrary.wiley.com
von PN Morcos — ... Florian Hiemeyer,. Florian Hiemeyer. Bayer AG, Berlin, Germany. Search for more papers by this author · Barrett H. Childs,. Barrett H. Childs.
Long-term safety and efficacy of the PI3K inhibitor ...Helsinki.fi
researchportal.helsinki.fi
Zitiert von: 122 — Florian Hiemeyer, MSc19 | Ashok Miriyala, MD20 | Jose Garcia-Vargas, MD20 |. Barrett H. Childs, MD20 | Pier Luigi Zinzani, MD21. 1Department of Medicine III ...
Sign in - ASCO Meeting - American Society of Clinical OncologyAmerican Society of Clinical Oncology (ASCO)
meetings.asco.org
... Florian Hiemeyer, Fatuma Odongo, Jose E. Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani. Organizations. LMU University Hospital, Munich, Germany, IRCCS ...
Abstract CT084: A randomized, double-blind phase III study of ...aacrjournals.org
aacrjournals.org
— Citation Format: Grzegorz S. Nowakowski, Igor Gorbatchevsky, Florian Hiemeyer, Lisa Cupit, Barrett H. Childs. A randomized, double-blind phase ...
Duration of Objective Responses for Patients with Indolent ...ScienceDirect.com
www.sciencedirect.com
von MJ Matasar · — ... Florian Hiemeyer 14, Barrett H Childs 13, Yuankai Shi 15, Pier Luigi Luigi Zinzani 16,17 1Department of Medicine, Memorial Sloan Kettering Cancer Center ...
Alle Infos zum Namen "Florian Hiemeyer"
Copanlisib in patients with relapsed or refractory follicular ...University of Helsinki
researchportal.helsinki.fi
... Florian Hiemeyer, Jose E. Garcia -Vargas, Barrett H. Childs, Pier Luigi Zinzani. Department of Oncology · HUS Comprehensive Cancer Center. Research output ...
Dr. Barrett Childs, MD – Riverdale, NY | OncologyDoximity
www.doximity.com
PI3K inhibitors in haematological malignancies. Matthew J Matasar, Florian Hiemeyer, Barrett H Childs, Pier Luigi Zinzani> ;The Lancet. Oncology Aug
PI3K inhibitors in haematological malignanciesNational Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von MJ Matasar · — Florian Hiemeyer , Barrett H Childs , Pier Luigi Zinzani. Affiliations. 1 Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY ...
Phase 2a study of copanlisib, a novel phosphatidylinositol- ...Research Explorer The University of Manchester
research.manchester.ac.uk
von K Linton · — ... Florian Hiemeyer, Marius Giurescu, Barrett H. Childs, David Cunningham. Research output: Contribution to conference › Other. Overview. Original language ...
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in ...Read by QxMD
read.qxmd.com
... Florian Hiemeyer, Jose Garcia-Vargas, Barrett H Childs, Pier Luigi Zinzani. Journal of Clinical Oncology December 11. Purpose Phosphatidylinositol
Single-agent activity of phosphatidylinositol Find an ExpertThe University of Melbourne
findanexpert.unimelb.edu.au
... Florian Hiemeyer, Paolo Piraino, Georg Beckmann, Carol Pena, Viktoriya Buvaylo, Barrett H Childs, Gilles Salles. LEUKEMIA | SPRINGERNATURE | Published :
Single-agent activity of phosphatidylinositol 3-kinase ...Elsevier
snucm.elsevierpure.com
von G Lenz · · Zitiert von: 54 — ... Florian Hiemeyer, Paolo Piraino, Georg Beckmann, Carol Peña, Viktoriya Buvaylo, Barrett H. Childs, Gilles Salles. Internal Medicine · SNUCM ...
Single-agent activity of phosphatidylinositol 3-kinase inhibition ...Elsevier
snucm.elsevierpure.com
... Florian Hiemeyer, Paolo Piraino, Georg Beckmann, Carol Peña, Viktoriya Buvaylo, Barrett H. Childs, Gilles Salles. Internal Medicine · SNUCM Internal Medicine ...
Single-agent activity of phosphatidylinositol 3-kinase inhibition ...Monash University
research.monash.edu
... Florian Hiemeyer, Paolo Piraino, Georg Beckmann, Carol Peña, Viktoriya Buvaylo, Barrett H. Childs, Gilles Salles. Eastern Health Clinical School. Research ...
E-MTAB < ArrayExpress < BioStudies ...EMBL-EBI
www.ebi.ac.uk
— ... Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, and Pier Luigi Zinzani. PI3K inhibition by copanlisib in relapsed or refractory ...
Paper: Results of the Mantle Cell Lymphoma Subset from a ...The Conference Exchange
ash.confex.com
— ... Florian Hiemeyer, PhD8*, Barrett H. Childs, MD12 and Martin H. Dreyling, MD, PhD13. 1The Royal Marsden Hospital, London and Surrey, United ...
APRIL , PENNSYLVANIA CONVENTION CENTER PHILADELPHIA, PA...
healthdocbox.com
Grzegorz S. Nowakowski, 1 Igor Gorbatchevsky, 2 Florian Hiemeyer, 3 Lisa Cupit, 2 Barrett H. Childs Mayo Clinic, Rochester, MN; 2 Bayer HealthCare ...
Altmetric – Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in...
www.altmetric.com
... Giurescu, Lisa Cupit, Li Liu, Karl Köchert, Henrik Seidel, Carol Peña, Shuxin Yin, Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani.
Copanlisib Treatment of Aggressive Lymphoma: Subset Analysis of...
www.research.manchester.ac.uk
... Mariano Provencio and Gilles Salles and Manoel Neves and Florian Hiemeyer and Liping Huang and Childs, {Barrett H.} and Igor Gorbatchevsky and Zinzani, ...
Phase 2a study of copanlisib, a novel phosphatidylinositol-3-kinase...
www.research.manchester.ac.uk
author = "Kim Linton and George Follows and Martin Dreyling and Julia Grunert and Florian Hiemeyer and Marius Giurescu and Childs, {Barrett H.} and David ...
sortiert nach Relevanz / Datum